Institutional ownership of Nike stands above 64 percent as multiple funds raised positions through Q3 2025. Analyst upgrades and executive insider buying reinforce the trend, with capital markets moving ahead of fiscal Q3 results due March 31.
Capital markets are moving in Nike’s direction. Ahead of its quarterly earnings report on March 31, a broad wave of institutional buying, upward analyst revisions and executive share purchases has taken shape — a confluence that suggests growing conviction in the brand’s recovery under new leadership.
Funds raised NKE exposure through Q3 2025
Securities and Exchange Commission (SEC) Form 13F filings from Q3 2025 show that multiple institutional investors added to their Nike positions during the July–September period. Coldstream Capital Management grew its holding by 50 percent, purchasing an additional 44,465 shares to reach a total of 133,337 shares valued at approximately $9.3 million.
The move was part of a wider pattern of accumulation. Exchange Traded Concepts LLC raised its NKE position by close to 700 percent, reaching 228,889 shares. Soros Fund Management LLC expanded its holding by 33 percent to 302,320 shares. Brighton Jones LLC increased its stake by around 55 percent. Israeli teachers’ pension fund Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD more than doubled its position to 205,082 shares, while Strive Asset Management LLC initiated a new stake in Nike during the same quarter. Institutional investors and hedge funds now hold 64.25 percent of Nike’s outstanding shares.
Analyst consensus tilts toward buy
The institutional trend is mirrored in sell-side sentiment. Based on ratings aggregated by MarketBeat, 23 analysts currently hold a Buy rating on NKE, 11 a Hold and one a Sell, placing the consensus at “Moderate Buy” with an average price target of $74.90.
Notable among recent moves, Barclays upgraded Nike from equal weight to overweight in March, raising its price target from $64 to $73, citing improving strategic momentum. Royal Bank of Canada has maintained an outperform rating with a $78 target. Goldman Sachs trimmed its target from $77 to $76 in late January but retained its buy recommendation, signaling continued confidence in the longer-term recovery thesis. Sanford C. Bernstein also reiterated a buy in early March.
Insider buying adds to the signal
Executives have aligned their own capital with the recovery narrative. Elliott Hill, who returned as Nike’s Chief Executive Officer in late 2024 after a period of retirement, purchased $1.0 million worth of NKE shares. Timothy D. Cook, Chief Executive Officer of Apple and a Nike board director since 2005, acquired approximately $2.95 million in shares in December 2025. Robert Holmes Swan, a former Intel chief executive who sits on Nike’s board, also made a purchase during the period.
Insider transactions are closely watched by markets because they reflect the perspective of individuals with direct knowledge of the company’s strategic and operational trajectory.
March 31 results will test recovery confidence
Nike’s upcoming results arrive at a critical juncture. The brand has navigated sustained pressure on multiple fronts: softening consumer demand across key markets, intensifying competition from performance footwear challengers, and a difficult recalibration of its direct-to-consumer model that weighed on wholesale relationships. Hill — who spent 25 years at Nike before leaving in 2020 — was brought back specifically to reset channel strategy and reinvigorate product momentum.
The brand’s most recent quarter provided early positive signals: Nike reported earnings per share of $0.53 against an analyst consensus of $0.37. The company also declared a quarterly dividend of $0.41 per share, equivalent to a 3.0 percent yield, with the ex-dividend date set for March 2. Whether the March 31 report confirms the pattern will be a key test of whether the capital confidence now building in the market is a leading indicator or an early overcorrection.
Go deeper: SEC Form 13F filings, Q3 2025
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.